News from Zyme and the companies we work with.
Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline
Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor Laurence Reid joins as Non-Executive Director, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Millennium Pharmaceuticals Cambridge, UK, 12 March 2025: Shift [...]
TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases
Oversubscribed financing led by Cambridge Innovation Capital and SV Health Investors’ Dementia Discovery Fund with M Ventures and Pfizer Ventures joining Investment will support further development of CNS penetrant therapeutics [...]
OBN Invites Life Science R&D Companies, Industry Leaders, Academics, and Investors to BioTrinity 2025
Opening keynote from Tim Haines, Executive Partner at Abingworth, to provide a review of the life science investment landscape Expected to welcome c900 delegates spanning early-stage life science R&D, investors, [...]
Centauri Therapeutics selects first clinical candidate, for immunotherapeutic treatment of Gram-negative bacterial infections
Lead candidate in the ABX-01 programme to progress into first-in-human clinical studies Programme designed to treat Gram-negative bacterial lung infections in the most vulnerable patients London, UK, 4 March 2025: [...]
FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility
Acquisition of Charles River site, previously Distributed Bio, strengthens antibody discovery capabilities with SuperHuman libraries and Yeast Display platform Established presence in major North American biotechnology cluster extends FairJourney’s global [...]
Sphere Fluidics rebrands to Sphere Bio
Supports Company’s global commercial growth, driven by customer demand for integrated life sciences tools and solutions Cambridge, UK, 25th February 2025: Sphere Fluidics today announced its rebranding to Sphere Bio. [...]
Nuclera appoints Seth Benson as Chief Financial Officer
Appointment to drive commercial growth of eProtein Discovery and support strategic expansion Cambridge, UK, 24 February 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein [...]
Sapio Sciences Expands Leadership Team to Drive Growth
Mike Hampton Joins as Chief Commercial Officer, and New Scientific Office Strengthens Sapio’s AI-Driven Lab Informatics Leadership Baltimore, MD, 18 February 2025 – Sapio Sciences, the science-aware™ lab informatics platform, [...]
Shift Bioscience establishes North American facilities to expand capabilities of AI-powered virtual cell technology
Head of Machine Learning, Lucas Camillo, to lead team with Professor Bo Wang, University of Toronto, appointed as Senior Advisor Expansion into global AI hub to accelerate growth of IP [...]
Nuclera appoints William J. Kullback as Non-Executive Director
Appointment of leading financial executive supports continued commercial development Current CFO at Telesis Bio, former CFO of BioLegend Inc. Cambridge, UK, 18 February 2025: Nuclera, the biotechnology company accelerating protein [...]
Antibodies.com and Cactus Communications partner to accelerate life science manuscript publication
Partnership provides Antibodies.com’s network of scientists with access to CACTUS’ editorial and publishing services to improve manuscript quality and increase publication success Cambridge, UK, and Mumbai, India, 06 February 2025: [...]
Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development
Ready-to-use kits expand portfolio of host cell protein impurity kits, for quantification of host cell proteins from HEK293 cell lines Kits developed through a collaboration with BioGenes GmbH Uppsala, Sweden, [...]
